Sort
Categories
- #EMSPVirtual2021
- Associate members
- Document
- EMSP Events
- EMSP Events|EMSP News
- EMSP News
- EMSP News|From Europe
- EMSP News|From Europe|Stakeholder Events
- EMSP News|MS Research
- EMSP News|Press Releases
- EMSP News|Young People with MS
- From Europe
- From Europe|Member News
- From Europe|Stakeholder Events
- From Europe|Young People with MS
- Full members
- Full members|Member News
- Member News
- Member News|Young People with MS
- MS Research
- News – EMSP
- Press Releases
- Stakeholder Events
- Uncategorized
- Young People with MS

Patient Voices: Shaping the Future of European Healthcare
As we reflect on the recent EU Health Summit, in the context of assessing the new priorities set by the…
EMSP Addresses MEP Interest Group on Critical MS Challenges in Europe
Elisabeth Kasilingam, CEO of the European Multiple Sclerosis Platform (EMSP), spoke at the MEP Interest Group on Brain Health and…
Reflecting on Progress: The EBV-MS Annual Consortium Meeting 2024
On November 25th and 26th, the picturesque city of Rome played host to the Annual Consortium Meeting of the EBV-MS…

Could the Epstein-Barr Virus hold the key for treatment and prevention of MS? BEHIND-MS Explores New Research Frontier
This week, leading researchers, clinicians, and patient advocates gathered in Heidelberg for the first annual meeting of the BEHIND-MS…
EMSP Advocates for Patient-Centered AI Development at Brain Innovation Days 2024
EMSP CEO, Elisabeth Kasilingam, joined leading experts at the Brain Innovation Days in Brussels on November 23-24 to discuss the…
EMSP at ECTRIMS 2024 – Key takeaways
EMSP delegates actively participated in the 40th Congress of the European Committee for Treatment and Research in Multiple Sclerosis ECTRIMS…

Unlocking the Mystery of MS: New BEHIND-MS Project Video Released
The BEHIND-MS project is proud to announce the release of a new video that introduces the project’s objectives and groundbreaking…
Presenting Key Insights from the IMSS Survey at ECTRIMS 2024
We are excited to share that the European Multiple Sclerosis Platform (EMSP) has presented the preliminary findings from the Impact…
Engaging Expert Patients: MS CAB and EBV-MS Project Team Collaborate on Clinical Trial Design
On June 19, 2024, the Multiple Sclerosis Community Advisory Board (MS CAB) met with the EBV-MS project research team for…